Horvath Susan is V.P. of Finance & CFO of Panbela Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Panbela Therapeutics, Inc.
29 Mar 23
4
Panbela Therapeutics, Inc.
1 Feb 23
4
Panbela Therapeutics, Inc.
15 Sep 21
4
Panbela Therapeutics, Inc.
1 Apr 21
4
Sun BioPharma, Inc.
1 Sep 20
4
Sun BioPharma, Inc.
26 Jun 20
4
Sun BioPharma, Inc.
9 Jun 20
4
Sun BioPharma, Inc.
26 Sep 19
4
Sun BioPharma, Inc.
4 Sep 19
4
Sun BioPharma, Inc.
2 Jul 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Mar 23 | PBLA Panbela Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.5 | 34,369 | 17.18 k | 34,369 |
30 Jan 23 | PBLA Panbela Therapeutics | Common Stock | Buy | Acquire P | No | No | 0 | 4,444 | 0.00 | 17,880 |
30 Jan 23 | PBLA Panbela Therapeutics | Warrants Common Stock | Buy | Acquire P | No | No | 2.75 | 8,888 | 24.44 k | 8,888 |